$0.3422
-0.04-9.71%
At close: -
$0.6499
0.3189.92%
After Hours: 7:59 PM EDT
Comments
Loading...
Reshape Lifesciences Earnings Estimates, EPS & Revenue | NASDAQ:RSLS | Benzinga
Reshape Lifesciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-3.110
Quarterly Revenue
$2.29M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$8.18M
Analyze the earnings history of Reshape Lifesciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RSLS | Reshape Lifesciences | -$5.22 | — | — | — | $1.94M | — | — | — | 05/14/2025 | Get Alert |
| RSLS | Reshape Lifesciences | -$6.38 | — | — | — | $1.98M | — | — | — | 04/21/2025 | Get Alert |
| RSLS | Reshape Lifesciences | -$59.36 | — | -$3.11 | — | $2.15M | $2.51M | $2.29M | -8.69% | 11/14/2024 | Get Alert |
| RSLS | Reshape Lifesciences | -$62.64 | — | -$3.48 | — | $2.25M | $2.21M | $1.97M | -11.09% | 08/14/2024 | Get Alert |
| RSLS | Reshape Lifesciences | -$90.48 | -$9.28 | -$5.22 | 43.75% | $2.29M | $2.10M | $1.94M | -7.43% | 05/15/2024 | Get Alert |
| RSLS | Reshape Lifesciences | -$2.06K | — | -$6.38 | — | $3.11M | — | $1.98M | — | 04/01/2024 | Get Alert |
| RSLS | Reshape Lifesciences | -$551.00 | -$69.60 | -$59.16 | 15.00% | $2.80M | $2.40M | $2.15M | -10.21% | 11/08/2023 | Get Alert |
| RSLS | Reshape Lifesciences | -$1.19K | -$103.82 | -$62.64 | 39.66% | $2.89M | $2.61M | $2.25M | -13.64% | 08/07/2023 | Get Alert |
| RSLS | Reshape Lifesciences | -$1.10K | -$244.18 | -$90.48 | 62.95% | $2.44M | $2.51M | $2.29M | -8.88% | 05/15/2023 | Get Alert |
| RSLS | Reshape Lifesciences | -$638.00 | -$580.00 | -$2.06K | -254.60% | $3.14M | $3.10M | $3.11M | 0.32% | 03/29/2023 | Get Alert |
| RSLS | Reshape Lifesciences | -$870.00 | -$1.01K | -$551.00 | 45.71% | $3.71M | $3.62M | $2.80M | -22.71% | 11/14/2022 | Get Alert |
| RSLS | Reshape Lifesciences | -$435.00 | -$1.01K | -$1.19K | -17.14% | $3.26M | $3.41M | $2.89M | -15.19% | 08/15/2022 | Get Alert |
| RSLS | Reshape Lifesciences | -$2.03K | -$493.00 | -$1.10K | -123.53% | $3.22M | $3.14M | $2.44M | -22.29% | 05/23/2022 | Get Alert |
| RSLS | Reshape Lifesciences | -$3.57K | -$493.00 | -$638.00 | -29.41% | $3.21M | $3.74M | $3.14M | -15.99% | 03/28/2022 | Get Alert |
| RSLS | Reshape Lifesciences | -$3.83K | -$435.00 | -$870.00 | -100.00% | $3.60M | $4.19M | $3.71M | — | 11/11/2021 | Get Alert |
| RSLS | Reshape Lifesciences | -$1.51K | — | -$435.00 | — | $1.70M | — | $3.26M | — | 08/05/2021 | Get Alert |
| RSLS | Reshape Lifesciences | -$1.42K | — | -$2.03K | — | $2.79M | — | $3.22M | — | 05/17/2021 | Get Alert |
| RSLS | Reshape Lifesciences | -$124.50K | — | -$71.34 | — | $4.10M | — | $3.21M | — | 03/10/2021 | Get Alert |
| RSLS | Reshape Lifesciences | -$308.68K | — | — | — | $3.52M | — | — | — | 11/12/2020 | Get Alert |
| RSLS | Reshape Lifesciences | -$3.63K | — | — | — | $4.45M | — | — | — | 08/13/2020 | Get Alert |
| RSLS | Reshape Lifesciences | -$1.57K | — | -$1.42K | — | $3.07M | — | $2.79M | — | 05/14/2020 | Get Alert |
Reshape Lifesciences (RSLS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-05-15 | $-5.22 | $-9.28 | 43.8 % |
| Q3 | 2023-11-08 | $-59.16 | $-69.60 | 15.0 % |
| Q2 | 2023-08-07 | $-62.64 | $-103.82 | 39.7 % |
| Q1 | 2023-05-15 | $-90.48 | $-244.18 | 62.9 % |
Reshape Lifesciences (RSLS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $2.29M | $2.51M | -8.69 % |
| Q2 | 2024-08-14 | $1.97M | $2.21M | -11.1 % |
| Q1 | 2024-05-15 | $1.94M | $2.10M | -7.43 % |
| Q3 | 2023-11-08 | $2.15M | $2.40M | -10.2 % |
FAQ
When is Reshape Lifesciences (NASDAQ:RSLS) reporting earnings?
Reshape Lifesciences (RSLS) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Reshape Lifesciences (NASDAQ:RSLS)?
The Actual EPS was $-3.11, which missed the estimate of $0.00.
What were Reshape Lifesciences’s (NASDAQ:RSLS) revenues?
The Actual Revenue was $2.3M, which missed the estimate of $2.5M.
Browse earnings estimates, EPS, and revenue on all stocks.